BiotechTube
Home/Vanqua Bio/Jack Beyer
JB

Jack Beyer

Chief Business Officer

Vanqua Bio

Therapeutic Areas

Parkinson's DiseaseAlzheimer's DiseaseDementia with Lewy BodiesNeurodegenerative Diseases

Vanqua Bio Pipeline

DrugIndicationPhase
GCase ActivatorGBA-Parkinson's DiseasePreclinical
Innate Immune System ModulatorAlzheimer's Disease / Related DisordersPreclinical

Leadership Team at Vanqua Bio

JS
Jim Sullivan, Ph.D.
Chief Executive Officer
KH
Kevin Hunt, Ph.D.
Chief Scientific Officer
OS
Omer Siddiqui
Chief Development Officer
MF
Maurizio Facheris, M.D.
Chief Medical Officer
View full Vanqua Bio profile